WellSpan Health
York, Pennsylvania
What changed
Study registered, no phase assigned: Oral Antibiotic Bowel Preparation in Gynecologic Oncology Surgery
Mar 2025Trial registeredMar 28, 2025Source filing (opens the source filing in a new tab)
Momentum
Momentum 60 out of 100, unchanged since the last recompute.
Some recent activity, at a steady rate.
Runway (estimate)
No disclosed raise on file, so there is nothing to model from.
Stage
Grant-only
The furthest-along thing in the public record. Not a projection.
Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.
Peer position
13,060 pre-ticker oncology companies at Grant-only
Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.
Compare seatsA ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.
Grant to raise
Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.
- Trial
Study registered
Dec 27, 2021Recurrent Endometrial Carcinoma · WITHDRAWN · sponsor: WellSpan Health · Endometrial Cancer Recurrence in Patients Taking Metformin
ClinicalTrials.gov · NCT05192850 (opens the source filing in a new tab)
- Trial
Study registered
Dec 22, 2021Surgical Site Infection, Surgical Complication, Gynecologic Cancer · COMPLETED · sponsor: WellSpan Health · Oral Antibiotic Bowel Preparation in Gynecologic Oncology Surgery
ClinicalTrials.gov · NCT05210556 (opens the source filing in a new tab)
- Trial
NA registered
Oct 15, 2020Endometrial Cancer · RECRUITING · sponsor: WellSpan Health · Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
ClinicalTrials.gov · NCT04570553 (opens the source filing in a new tab)
- Trial
Study registered
May 8, 2019Lynch Syndrome, Endometrial Cancer, Endometrial Hyperplasia, Mismatch Repair Deficiency, Microsatellite Instability · COMPLETED · sponsor: WellSpan Health · Frequency of Endometrial Cancer Precursors Associated with Lynch Syndrome
ClinicalTrials.gov · NCT05257057 (opens the source filing in a new tab)
Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources